Back to top

Apogee Therapeutics (APGE) Receives a Hold from Truist Financial

In a report released today, Danielle Brill from Truist Financial maintained a Hold rating on Apogee Therapeutics, with a price target of $135.00. A...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Apogee Therapeutics Inc. (APGE)